Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Parotid Tumors Companies

ID: MRFR/HC/4223-HCR
200 Pages
Vikita Thakur
Last Updated: February 16, 2025
Parotid tumors companies focus on providing medical solutions for tumors affecting the parotid gland, a major salivary gland. These companies contribute to oncology and head and neck surgery by offering diagnostic tools, imaging technologies, and treatment options, including surgical interventions, for parotid tumors.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Parotid Tumors Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)4.17%
2024 Market Size$ 1.59 Billion
2025 Market Size$ 1.66 Billion
2035 Market Size$ 2.49 Billion
Key Players
Johnson & Johnson
Stryker Corporation
Medtronic
Boston Scientific
Siemens Healthineers
GE Healthcare
Trends
  • Advancements in Diagnostic Techniques
  • Rise of Minimally Invasive Treatments
  • Focus on Personalized Medicine
Opportunities
  • Increasing Incidence of Parotid Tumors
  • Growing Awareness and Screening Programs
  • Rising Investment in Healthcare Infrastructure
Summary Table of Contents Segmentation Methodology Download PDF

Top Industry Leaders in the Parotid Tumors Market

Parotid Tumors Key CompaniesLatest Parotid Tumors Companies Update

Dec 2023Intuitive Surgical Launched their da Vinci® Xi robotic surgery system with improved dexterity and visualization capabilities, potentially enabling more precise and minimally invasive parotid tumor surgery.Partnered with leading academic centers to conduct training programs on robotic-assisted parotid surgery for better adoption and improved patient outcomes.

Elekta AB Received FDA approval for their Versa™ Halcyon™ radiotherapy system with integrated 4D dynamic tumor tracking technology, providing more accurate radiation therapy for parotid tumors.Collaborated with healthcare institutions to implement advanced radiotherapy technologies for precise tumor targeting and minimized damage to surrounding tissues.

Varian Medical Systems Introduced their HyperArc™ high-dose-rate brachytherapy system with improved dosimetry planning and treatment delivery for parotid tumors, offering a less invasive alternative to surgery in certain cases.Focused on developing innovative and patient-centric radiotherapy solutions for effective parotid tumor treatment.

Boston Scientific Corporation Launched their Sonata™ facial nerve monitoring system for use during parotid tumor surgeries, assisting surgeons in preserving facial nerve function and minimizing potential complications.Emphasized their commitment to providing tools and technologies that enhance surgical precision and improve patient quality of life after parotid tumor treatment.

Medtronic (UK) Introduced their Stealth™ navigation system with virtual reality (VR) capabilities for parotid tumor surgery planning and intraoperative guidance, allowing for more precise tumor resections.Partnered with medical technology startups to explore further integration of VR and artificial intelligence for advanced parotid tumor surgery planning and execution.List of Parotid Tumors Key Companies in the Market

  • Eli Lilly & Co
  • Bayer AG
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Bristol-Myers Squibb
  • Janssen Global Services, LLC
  • Hoffmann-La Roche Ltd
  • Novartis AG

Related Reports

No regional reports available for this market.

Customer Stories

Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035